-
Signature
-
/s/ Swathi Padmanabhan as attorney-in-fact for Mark Pearson
-
Issuer symbol
-
EQH
-
Transactions as of
-
20 Jan 2026
-
Net transactions value
-
-$1,834,298
-
Form type
-
4
-
Filing time
-
21 Jan 2026, 16:10:06 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Pearson Mark |
President and CEO, Director |
C/O EQUITABLE HOLDINGS, INC., 1345 AVENUE OF THE AMERICAS, NEW YORK |
/s/ Swathi Padmanabhan as attorney-in-fact for Mark Pearson |
21 Jan 2026 |
0001512442 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
EQH |
Common Stock |
Options Exercise |
$630,496 |
+27,200 |
+4.1% |
$23.18 |
692,645 |
20 Jan 2026 |
Direct |
F1, F2 |
| transaction |
EQH |
Common Stock |
Sale |
$1,560,131 |
-33,838 |
-4.9% |
$46.11 |
658,807 |
20 Jan 2026 |
Direct |
F1, F2, F3 |
| transaction |
EQH |
Common Stock |
Sale |
$274,166 |
-5,862 |
-0.89% |
$46.77 |
652,945 |
20 Jan 2026 |
Direct |
F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
EQH |
Employee Stock Option (right to buy) |
Options Exercise |
$630,496 |
-27,200 |
-14% |
$23.18 |
163,200 |
20 Jan 2026 |
Common Stock |
27,200 |
$23.18 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: